Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned

Abstract International regulatory authorities and funders require that research be disseminated promptly and appropriately to all involved stakeholders. However, following completion of clinical trials participants often either do not receive any feedback or materials provided are not appropriate fo...

Full description

Bibliographic Details
Published in:Malaria Journal
Main Authors: Tamiru S. Degaga, Sophie Weston, Tedla T. Tego, Dagimawie T. Abate, Ashenafi Aseffa, Adugna Wayessa, Ric N. Price, Asrat Hailu, Kamala Thriemer
Format: Article in Journal/Newspaper
Language:English
Published: BMC 2020
Subjects:
Clinical trial
Result dissemination
Participant experience
Participant feedback
Patient feedback
Malaria
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
Arctic
Online Access:https://doi.org/10.1186/s12936-020-03279-5
https://doaj.org/article/a4cf3c5d1f134866b7db91c9161ad6de
Description
Summary:Abstract International regulatory authorities and funders require that research be disseminated promptly and appropriately to all involved stakeholders. However, following completion of clinical trials participants often either do not receive any feedback or materials provided are not appropriate for the context. The investigators of a multicentre anti-malarial clinical trial (the IMPROV study) conducted a dissemination meeting at one of the study sites in Ethiopia; trial participants and medical staff were provided feedback on the study results. This report summarizes the dissemination strategies adopted by the investigators, including a plain language visual aid and simple communication techniques. Lessons learned are reported with a discussion on the operational challenges to dissemination of clinical trials in resource limited settings.

Similar Items